Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2009-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2008.091553PMID 19366897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.

  2007cited by this paper
• Eprodisate for the treatment of renal disease in AA amyloidosis.

  2007influential reference
• Ankylosing spondylitis-related secondary amyloidosis responded well to etanercept: a report of three patients

  2007cited by this paper
• Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis

  2004cited by this paper
• Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.

  2003cited by this paper
• Benefit of anti-TNF a treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis

  2003influential reference
• Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.

  2002cited by this paper
• Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone.

  2000cited by this paper

• Rheumatoid Arthritis.

  2019cites this paper
• The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review

  2017cites this paper
• Chapter 62 – Immunosuppressive Drugs

  2017cites this paper
• Cytostatic and cytotoxic drugs

  2014cites this paper
• 62 – Immunosuppressive Drugs

  2013cites this paper
• A New Approach to Clinical Care of Juvenile Idiopathic Arthritis: The Juvenile Arthritis Multidimensional Assessment Report

  2011cites this paper
• Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus

  2011cites this paper
• Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis

  2010cites this paper
• Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment

  2010cites this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

  2010cites this paper
• Systemic combination treatment for psoriasis: a review.

  2010cites this paper
• Treating rheumatoid arthritis to target: recommendations of an international task force

  2010cites this paper
• Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate

  2010cites this paper
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

  2010cites this paper
• Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)

  2009cites this paper
• A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools

  2009cites this paper
• Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients

  2009cites this paper
• Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe

  2009cites this paper
• Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population

  2009cites this paper
• Diagnosing axial spondyloarthropathy. The new Assessment in SpondyloArthritis international Society criteria: MRI entering centre stage

  2009cites this paper
• No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort

  2009cites this paper
• Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level

  2009cites this paper
• Buch, M. H. et al. (2009) Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging

  2009cites this paper
• Циклоспорин а при ревматоидном артрите: современные данные

  2009cites this paper
• The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy

  2009cites this paper
• Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence

  2008cites this paper
• The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus

  2008cites this paper
• Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

  2008cites this paper
• Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study

  2008cites this paper
• Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

  2008cites this paper
• Extended Report

  year unknowncites this paper